SCHEMBL21828993

SCHEMBL21828993

O=C(Nc1cccc2ccccc12)c1ccc(Cl)cc1Cl

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIK1 P39086 1/20 0.64
PTGES O14684 1/20 0.62
RAB9A P51151 6/20 0.60
NPC1 O15118 5/20 0.60
MEN1 O00255 4/20 0.60
KMT2A Q03164 4/20 0.60
GAA P10253 3/20 0.60
MAPT P10636 2/20 0.60
KDM4E B2RXH2 2/20 0.60
RORC P51449 1/20 0.58
HSD17B10 Q99714 1/20 0.58
ALDH1A1 P00352 3/20 0.57
TAS1R3 Q7RTX0 1/20 0.56
TAS1R1 Q7RTX1 1/20 0.56
TAS1R2 Q8TE23 1/20 0.56
CYP2C19 P33261 2/20 0.55
CYP1A2 P05177 1/20 0.55
CYP3A4 P08684 1/20 0.55
CYP2D6 P10635 1/20 0.55
CYP2C9 P11712 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5448004 0.87 ALDH1A1 (0.72) GRIK1RAB9ANPC1MEN1KMT2A
SCHEMBL24004566 0.86 GRIK1 (0.61) GRIK1PTGESRAB9ANPC1MEN1
SCHEMBL21828990 0.86 RAB9A (0.72) GRIK1PTGESRAB9ANPC1MEN1
SCHEMBL24004522 0.86 GRIK1 (0.61) GRIK1PTGESRAB9ANPC1MEN1
SCHEMBL21828995 0.86 PTGES (0.59) GRIK1PTGESRAB9ANPC1MEN1
SCHEMBL21828982 0.86 PTGES (0.59) GRIK1PTGESRAB9ANPC1MEN1
SCHEMBL6357071 0.85 PTGES (0.76) PTGESRAB9ANPC1MEN1KMT2A
SCHEMBL330342 0.84 KDR (0.65) GRIK1PTGESRAB9ANPC1MEN1
SCHEMBL9901505 0.83 CYP2C19 (0.72) GRIK1RAB9ANPC1MEN1KMT2A
SCHEMBL12748826 0.81 RAB9A (0.61) RAB9ANPC1MEN1KMT2AGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210347752-A1 BENZAMIDE DERIVATIVES AS CGAS-STING PATHWAY AGONISTS BARUCH S. BLUMBERG INSTITUTE 2021-11-11 US claimed
CN-112888688-A Benzamide derivatives as CGAS-STING pathway agonists 巴鲁克斯布伦博格研究所 2021-06-01 CN claimed
WO-2020072492-A1 BENZAMIDE DERIVATIVES AS CGAS-STING PATHWAY AGONISTS BARUCH S. BLUMBERG INSTITUTE (US) 2020-04-09 WO claimed
US-12509436-B2 Benzamide derivatives as cGAS-sting pathway agonists BARUCH S. BLUMBERG INSTITUTE (US) 2025-12-30 US disclosed
US-20210347752-A1 BENZAMIDE DERIVATIVES AS CGAS-STING PATHWAY AGONISTS BARUCH S. BLUMBERG INSTITUTE 2021-11-11 US disclosed
US-20210347752-A1 BENZAMIDE DERIVATIVES AS CGAS-STING PATHWAY AGONISTS BARUCH S. BLUMBERG INSTITUTE 2021-11-11 US disclosed
CN-112888688-A Benzamide derivatives as CGAS-STING pathway agonists 巴鲁克斯布伦博格研究所 2021-06-01 CN disclosed
WO-2020072492-A1 BENZAMIDE DERIVATIVES AS CGAS-STING PATHWAY AGONISTS BARUCH S. BLUMBERG INSTITUTE (US) 2020-04-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12509436-B2 Benzamide derivatives as cGAS-sting pathway agonists STING1, CGAS, IFNAR1 GRIK1 2504/4885PTGES 3541/4885RAB9A 370/4885
US-20210347752-A1 BENZAMIDE DERIVATIVES AS CGAS-STING PATHWAY AGONISTS STING1, CGAS, MAVS GRIK1 3430/4885PTGES 1070/4885RAB9A 1646/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.